TABLE 1.
Gene | Orientationa | Sequence (5′ to 3′)b |
---|---|---|
hTLR4 | upper-1 | AT GGA TCC ACC ATG ATG TCT GCC TCG CGC CTG |
upper-2 | AC CGA AGC TTG TCC TGC GTG AGA CCA GAA AGC TG | |
lower | TAA ATT CTC GAGTCA GAT AGA TGT TGC TTC CTG CCA | |
mTLR4 | upper-1 | GAA GGA TCCACC ATG ATG CCT CCC TGG CTC CTG |
upper-2 | GGG GTA CCG TCC TGC CTG ACA CCA GGA AGC TTG | |
lower | C AGA GTT TGC GGC CGCTCA GGT CCA AGT TGC CGT TTC TTG | |
hMD-2 | upper-1 | G GAA TTC ACC ATG TTA CCA TTT CTG TTT TTT TCC ACC |
upper-2 | ACC GAA GCT TTG GAA GCT CAG AAG CAG TAT TGG GTC | |
lower | GC TCT AGACTA ATT TGA ATT AGG TTG GTG TAG GAT | |
mMD-2 | upper-1 | G GAA TTC ACC ATG TTG CCA TTT ATT CTC TTT TCG ACG |
upper-2 | AT TAA AGC TTG GAA TCT GAG AAG CAA CAG TGG | |
lower | CCG CTC TAG ATT TTT TTT TTT TTT TTT Tc |
The upper-1 and upper-2 primers were used to amplify the entire coding region and the coding region minus the signal peptide sequence, respectively.
Sequences in italics and boldface indicate restriction sites created and the respective coding regions, respectively.
Since the 3′ portion of the mMD-2 sequence had not been determined at the time of creation, an oligo(dT) primer was used.